Surmodics (SRDX)
(Delayed Data from NSDQ)
$39.63 USD
-0.04 (-0.10%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $39.62 -0.01 (-0.03%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth B Momentum B VGM
Brokerage Reports
Surmodics, Inc. [SRDX]
Reports for Purchase
Showing records 281 - 300 ( 419 total )
Company: Surmodics, Inc.
Industry: Medical - Products
Q3 well ahead of estimates -''''The Whiskey'''' not to be shared
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Q2 well ahead of estimates - DCB trial begins - ''''whole products'''' strategy on track
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
First enrollment in SurVeil drug-coated balloon study, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Q1 well ahead of estimates - "whole products" strategy potentially massive
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Provides updated guidance following Creagh Medical acquisition
Provider: Feltl & Company
Analyst: HAYNOR B